|
Software Failures Behind Many Recalls: Design to Avoid Them, Expert Says
The FDA is developing new methods and laboratory expertise to aid reviewers in identifying potential vulnerabilities and assessing risk mitigation measures for medical software. The agency also is considering reverse engineering certain types of malware to identify specific protective practices devicemakers should be employing to prevent cybersecurity breaches.
The GMP Letter |
|
Register Now
Archives